Immunodiagnostics Market: Latest Report Highlights 2030

The global Immunodiagnostics Market is projected to reach USD 27.07 billion by 2030, growing at a CAGR of 3.9%. This growth is driven by the rising prevalence of infectious diseases, such as respiratory infections and HIV, along with an aging population that requires more diagnostic tests. The growing demand for effective diagnostic tools is further fueled by increased healthcare awareness and advancements in immunodiagnostic technologies.

Download FREE Sample: https://www.nextmsc.com/immunodiagnostics-market/request-sample

Despite these positive trends, the market faces challenges such as the high cost of diagnostic tests and stringent regulations that can limit market expansion. However, ongoing advancements in diagnostic kits, assays, and analyzers, as well as heightened awareness about preventive health, are expected to create significant growth opportunities.

North America dominates the immunodiagnostics market, owing to the high demand for diagnostic tests, a large geriatric population, and the growing prevalence of chronic and infectious diseases.

Key market players in the immunodiagnostics space include Abbott Laboratories, Arkray Inc., Immunodiagnostic Systems Holdings plc (IDS), Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, Johnson & Johnson, Danaher Corporation, Sysmex Corporation, and Thermo Fisher Scientific Inc. These companies are focusing on innovation and strategic partnerships to expand their market presence.